Een vrouw met lang blond haar die een mouwloos zwart topje en een halsketting draagt, glimlacht terwijl ze in een heldere, wazige omgeving van een advocatenkantoor staat.

Monica R. Chmielewski

Partner

Monica R. Chmielewski

Partner

Monica R. Chmielewski is a health care and life sciences lawyer solely focused on the representation of health care providers, pharmaceutical, biotech and medical device companies, and pharmacies in life sciences law, health care, health care transactions, clinical research, supply chain, and food and drug law. She has experience assisting clients with regards to all aspects of medical research, development and commercialization, including regarding the regulation and conduct of clinical trials and decentralized clinical trials, FDA submissions and pharmaceutical and medical device manufacturing, licensing and commercialization assistance. She is a partner and vice chair of the firm’s Health Care Practice Group.

Representatieve ervaring

Regulatory Compliance, Clinical Research, and Supply Chain

Monica provides daily counsel to numerous health systems, hospitals, academic medical centers, pharmacies and biotech, pharmaceutical and medical device companies. As such, she regularly assists clients with the following issues:

  • Regulatory compliance governing all aspects of clinical research
  • Investigations of research misconduct
  • Institutional Review Board (IRB) issues
  • The conduct of U.S. and international clinical trials
  • Research grants and funding
  • Government investigations and audits
  • Pharmaceutical product promotion (including counsel on off-label promotion)
  • 510K applications
  • The regulation of software as a medical device
  • Mobile medical applications
  • Continuing Medical Education (CME)
  • Preparation of research contracts
  • Grant contracts and administration
  • Pharmacy Benefit Managers (PBM) matters
  • Good clinical practice (GCP) issues
  • Customs import and export issues
  • Hospital and physician issues
  • Supply chain matters (including formation of and contracting with group purchasing organizations)
  • Corporate practice of medicine and dentistry prohibitions
  • Joint venture and other collaborative efforts
  • Preparation and review of hospital
  • Physician and other provider contracts
  • Accountable care organization (ACO) formation and operation
  • HIPAA
  • Physician recruitment
  • Corporate compliance issues
  • Medical staff and peer review
  • Accreditation matters
  • Supply chain and procurement issues

She also has participated as transactional counsel in numerous health care, life science, and corporate transactions, including the merger, purchase and sale, or transfer of sponsorship of hospitals, pharmacies, contract research organizations (CROs), physician-owned surgery centers, health systems, home health agencies, hospices and physician practices; and the formation of ancillary services joint ventures; and counsels investors (venture capital and private equity) in investments, acquisitions, and sales.

Monica has in-depth knowledge of federal and state regulation of the drug and device supply chain, pharmacies, and laboratories. She advises entities (industry), health care providers, investors, and lenders on transactional matters and regulatory compliance, including mergers and acquisitions, recapitalizations, buyouts, restructurings, joint ventures, and broad range of commercial transactions.

Monica provides daily counsel on supply chain and materials management issues, and counsels on group purchasing organization (GPO) negotiations and formation. She also counsels health plans in their procurement of and contracting with PBMs for mail, retail, and specialty drug services in connection with commercial and government health care programs. In addition, she provides counsel regarding PBM audits, as well as on regulatory issues for various retail and specialty pharmacies, including state Boards of Pharmacy inspection and adverse findings, compounding pharmacy matters, and licensure among others.

Naleving

Monica counsels health care entities, pharmaceutical and medical device companies, pharmacies and laboratories regarding the operation and functions of their corporate compliance and integrity programs, including assisting with the composition and development of programs; reviewing and assessing existing program effectiveness; providing compliance education and training of personnel, executive management and board members; coordinating internal investigations of compliance related concerns; and recommending any needed corrective action. She has counseled, in both in-house and outside counsel roles, individual hospitals, health systems, hospices, skilled nursing facilities, and pharmaceutical companies on matters of corporate compliance.

Telegeneeskunde

"Foley is het belangrijkste bedrijf voor advies op het gebied van telegeneeskunde."
"Een marktleider op het gebied van telegeneeskunde." "Dit is het dreamteam."
- Chambers USA: America's Leading Business Lawyers (2020, 2021)

Monica advises a number of clients, including hospitals, health systems and physician groups on regulatory and compliance issues presented by telemedicine and telehealth. Her counsel includes, but is not limited to, structuring, and negotiating professional services agreements for telemedicine services and composing telemedicine policies and procures.

Fraud and Abuse, False Claim Act, and Health Care Fraud Investigations

Monica’s experience includes particular compliance issues arising under the False Claims Act (FCA), Stark Law, Anti-Kickback Statute, EMTALA, Civil Monetary Penalties Law, licensure/certification, and HIPAA. Monica works with providers on properly responding to governmental and accreditation audits and more formal investigations as well as directly with provider compliance officers and general counsel to advise them on the latest legal and Office of Inspector General requirements and standards.

Prijzen en erkenning

  • Chambers USA: America’s Leading Business Lawyers, Healthcare: Pharmaceutical/Medical Products Regulatory (2020-2025)
  • The Legal 500, Life Sciences (2014)
  • Named a Thomson Reuters Stand-out Lawyer (2023-2024)

Presentaties en publicaties

  • Co-auteur, "GLP-1 receptoragonisten: Overwegingen voor klinisch onderzoek", Health Care Law Today (22 juli 2025).
  • Co-auteur, "Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule," Health Care Law Today (2 april 2025).
  • Co-auteur, "FDA & OHRP Ontwerprichtlijnen: Including Tissue Biopsies in Clinical Trials", Health Care Law Today (3 februari 2025).
  • Co-auteur, "FDA Clinical Investigations: New Guidance on Electronic Systems", Health Care Law Today (20 november 2024).
  • Co-auteur, "Kankergeneesmiddelen: Clinical Trial Issues for Antibody Drug Conjugates (ADC's)/Antibody Therapeutics", Health Care Law Today (5 november 2024).
  • Speaker, “Medical Research Misconduct Proceedings: New HHS-ORI Final Rule; Key Procedural Reforms and Requirements,“ Strafford Webinar (December 4, 2024)
  • Co-auteur, "Gedecentraliseerd klinisch onderzoek: Risico's van wangedrag bij onderzoek & hoe ze te vermijden", Health Care Law Today (30 september 2024).
  • Speaker, “Examine the Recent FDA Guidance Surrounding Digital Health Technologies,“ 5th Clinical Trial Agreements (August 22, 2024)
  • Co-auteur, "Klinische proeven: FDA Publishes Draft Guidance on Diversity Action Plans," Health Care Law Today (25 juli 2024).
18 september 2025 Evenementen

GLP-1 geneesmiddelen in beeld: Trends, behoeften en de toekomst

De sectoren Health Care & Life Sciences en Innovative Technology van Foley nodigen u uit voor een webinar over hoe uw organisatie kan navigeren op het kruispunt van GLP-1's en zich kan voorbereiden op dit veranderende landschap.
October 6, 2025 Events

Women, Influence & Power in Law Conference 2025

ALM will be hosting its annual Women, Influence & Power in Law conference on October 6-8 in Washington D.C. at the Gaylord National Resort & Convention Center.
Een wetenschapper met een beschermende bril bekijkt monsters onder een microscoop terwijl hij twee reageerbuizen vasthoudt in een laboratorium. Dit levert cruciaal onderzoek op dat kan helpen bij intellectueel eigendomsrecht en ondersteuning bij rechtszaken voor advocaten in Chicago.
July 22, 2025 Health Care Law Today

GLP-1-receptoragonisten: overwegingen bij klinische onderzoeken

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®).
Aan de muur bevestigde medische apparatuur, waaronder een bloeddrukmeter, otoscoop, oftalmoscoop, thermometer en containers voor wegwerphoezen in een klinische omgeving, vaak aangetroffen in advocatenkantoren in Chicago die ter plaatse gezondheidsdiensten aanbieden.
16 juli 2025 Gezondheidszorg Recht Vandaag Podcast

Aflevering 36: Laten we het hebben over compliance: De risico's en valkuilen van naleving van de toeleveringsketen in de gezondheidszorg

In deze aflevering onderzoeken Monica Chmielewski, vicevoorzitter van Foley's Health Care Practice Group en Shannon Sumner, Chief Compliance Officer en Nashville's Office Managing Principal van PYA, hoe compliance van de toeleveringsketen de gezondheidszorg beïnvloedt en welke risico's en boetes er verbonden zijn aan het niet naleven van de regels.
July 23, 2025 Events

Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact

Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.
5 juni 2025 Persberichten

Foley behaalt toppositie in Chambers USA 2025

Foley & Lardner LLP is er trots op opnieuw door Chambers & Partners erkend te worden als een van de toonaangevende advocatenkantoren in het land in de 2025 editie van Chambers USA: America's Leading Lawyers for Business.